EarningsQ2 2024 Earnings Report

ACADIA Pharmaceuticals (ACAD) Q2 2024 Earnings Report

0 Followers

MX:ACAD Q2 2024 EPS Results

Actual EPS$3.62

Consensus EPS$3.22

Beat/MissBeat by +$0.40

One Year Ago EPS$0.18

Actual Revenue$4.38B

Expected Revenue$4.27B

Beat/MissBeat by +$108.88M

YoY Revenue Growth+46.44%

QuarterQ2 2024

Date08/06/2024

TimeAfter Close

Conference CallTuesday, August 6, 2024

MX:ACAD Upcoming Earnings

ACADIA Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:ACAD Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	3.58 / -	7.6	―
Aug 04, 2026	2026 (Q2)	1.23 / 3.26	2.895	12.50% (+0.36)
May 06, 2026	2026 (Q1)	0.92 / 0.36	1.99	-81.82% (-1.63)
Feb 25, 2026	2025 (Q4)	2.48 / 28.95	15.562	86.05% (+13.39)
Nov 05, 2025	2025 (Q3)	3.13 / 7.60	3.619	110.00% (+3.98)
Aug 06, 2025	2025 (Q2)	2.50 / 2.90	3.619	-20.00% (-0.72)
May 07, 2025	2025 (Q1)	1.57 / 1.99	1.81	10.00% (+0.18)
Feb 26, 2025	2024 (Q4)	3.91 / 15.56	5.067	207.14% (+10.50)
Nov 06, 2024	2024 (Q3)	2.50 / 3.62	-7.238	150.00% (+10.86)
Aug 06, 2024	2024 (Q2)	3.22 / 3.62	0.181	1900.00% (+3.44)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed